Literature DB >> 22561735

Oscillometric estimation of central blood pressure: validation of the Mobil-O-Graph in comparison with the SphygmoCor device.

Wolfgang Weiss1, Christopher Gohlisch, Christl Harsch-Gladisch, Markus Tölle, Walter Zidek, Markus van der Giet.   

Abstract

BACKGROUND: Hypertension is a major risk factor for a wide range of cardiovascular diseases and is typically identified by measuring blood pressure (BP) at the brachial artery. Although such a measurement may accurately determine diastolic BP, systolic BP is not reflected accurately. Current noninvasive techniques for assessing central aortic BP require additional recording of an arterial pressure wave using a high-fidelity applanation tonometer. Within one measurement cycle, the Mobil-O-Graph BP device uses brachial oscillometric BP waves for a noninvasive estimation of central BP. We therefore validated the Mobil-O-Graph against the SphygmoCor device, which is widely known as the commonly used approach for a noninvasive estimation of central BP.
METHODS: For each individual, we compared three readings of the central BP values obtained by the Mobil-O-Graph and SphygmoCor device consecutively. One hundred individuals (mean age 56.1 ± 15.4 years) were recruited for measurement.Differences between the central BP values of the test device and the SphygmoCor device were calculated for each measurement.
RESULTS: The mean difference (95% confidence interval) for the estimated central systolic BP between both devices was -0.6 ± 3.7 mmHg. Comparison of the central BP values measured by the two devices showed a statistically significant linear correlation (R=0.91, P<0.0001). The mean between-method difference was 0.50 mmHg for central systolic BP estimation. The intrarater reproducibility between both the devices was also comparable. Bland and Altman analyses showed that the mean differences (95% confidence interval) between repeated measurements were 1.89 (0.42-3.36) mmHg and 1.36 (-0.16 to 2.83) mmHg for the SphygmoCor and the Mobil-O-Graph device, respectively. Thus, neither of these differences was statistically significantly different from 0. The limits of agreement were -16.34 to 19.73 and -15.23 to 17.17 mmHg for the SphygmoCor and the Mobil-O-Graph device, respectively.
CONCLUSION: Oscillometric noninvasive estimation of central BP with the Mobil-O-Graph BP device is as effective as using the well-established SphygmoCor applanation tonometry device. In comparison, the Mobil-O-Graph combines the widespread benefits of brachial BP measurement and also provides central BP within one measurement.

Entities:  

Mesh:

Year:  2012        PMID: 22561735     DOI: 10.1097/MBP.0b013e328353ff63

Source DB:  PubMed          Journal:  Blood Press Monit        ISSN: 1359-5237            Impact factor:   1.444


  71 in total

1.  Association of left ventricular diastolic dysfunction with 24-h aortic ambulatory blood pressure: the SAFAR study.

Authors:  Y Zhang; G Kollias; A A Argyris; T G Papaioannou; C Tountas; G D Konstantonis; A Achimastos; J Blacher; M E Safar; P P Sfikakis; A D Protogerou
Journal:  J Hum Hypertens       Date:  2014-11-13       Impact factor: 3.012

Review 2.  Impact of Antihypertensive Agents on Central Systolic Blood Pressure and Augmentation Index: A Meta-Analysis.

Authors:  Tracey J McGaughey; Emily A Fletcher; Sachin A Shah
Journal:  Am J Hypertens       Date:  2015-08-19       Impact factor: 2.689

3.  Ambulatory blood pressure and arterial stiffness in individuals with type 1 diabetes.

Authors:  Raija Lithovius; Daniel Gordin; Carol Forsblom; Markku Saraheimo; Valma Harjutsalo; Per-Henrik Groop
Journal:  Diabetologia       Date:  2018-05-24       Impact factor: 10.122

4.  Ambulatory aortic blood pressure, wave reflections and pulse wave velocity are elevated during the third in comparison to the second interdialytic day of the long interval in chronic haemodialysis patients.

Authors:  Georgios Koutroumbas; Panagiotis I Georgianos; Pantelis A Sarafidis; Athanase Protogerou; Antonios Karpetas; Pantelis Vakianis; Vassilios Raptis; Vassilios Liakopoulos; Stylianos Panagoutsos; Christos Syrganis; Ploumis Passadakis
Journal:  Nephrol Dial Transplant       Date:  2015-04-28       Impact factor: 5.992

5.  Effect of supraphysiological estrogen levels on arterial stiffness and hemodynamic parameters.

Authors:  Murat Akçay; Ayşe Zehra Özdemir
Journal:  Anatol J Cardiol       Date:  2021-05       Impact factor: 1.596

6.  The Impact of Measurement Methods on Office Blood Pressure and Management of Hypertension in General Practice.

Authors:  Julia Höller; Linda Elizabeth Villagomez Fuentes; Klaus Matthias; Reinhold Kreutz
Journal:  High Blood Press Cardiovasc Prev       Date:  2019-11-09

7.  Augmentation index, a predictor of cardiovascular events, is increased in children and adolescents with primary nephrotic syndrome.

Authors:  Cláudia Alves; José Felippe Pinho; Luzia Maria Dos Santos; Giselle Magalhães; Júnia Maria da Silva; Fernanda Luiza Fontes; Sordaini Maria Caligiorne; Sérgio Pinheiro; Maria Glória Rodrigues-Machado
Journal:  Pediatr Nephrol       Date:  2019-12-16       Impact factor: 3.714

8.  Frequency of early vascular aging and associated risk factors among an adult population in Latin America: the OPTIMO study.

Authors:  Fernando Botto; Sebastian Obregon; Fernando Rubinstein; Angelo Scuteri; Peter M Nilsson; Carol Kotliar
Journal:  J Hum Hypertens       Date:  2018-02-20       Impact factor: 3.012

9.  Increased Levels of Modified Advanced Oxidation Protein Products Are Associated with Central and Peripheral Blood Pressure in Peritoneal Dialysis Patients.

Authors:  Hong Xu; Ivan Cabezas-Rodriguez; Abdul Rashid Qureshi; Olof Heimburger; Peter Barany; Sunna Snaedal; Björn Anderstam; Ann-Christin Bragfors Helin; Juan Jesus Carrero; Peter Stenvinkel; Bengt Lindholm
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

Review 10.  Twenty-Four-Hour Ambulatory Pulse Wave Analysis in Hypertension Management: Current Evidence and Perspectives.

Authors:  Stefano Omboni; Igor N Posokhov; Yulia V Kotovskaya; Athanase D Protogerou; Jacques Blacher
Journal:  Curr Hypertens Rep       Date:  2016-10       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.